BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 23146464)

  • 1. Anemia in kidney transplants without erythropoietic agents: levels of erythropoietin and iron parameters.
    Florit EA; Hadad F; Rodriguez Cubillo B; De la Flor JC; Valga F; Perez Flores I; Calvo Romero N; Valero San Cecilio R; Barrientos Guzman A; Sanchez Fructuoso A
    Transplant Proc; 2012 Nov; 44(9):2590-2. PubMed ID: 23146464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of anemia with erythropoietin-stimulating agents in kidney transplant recipients and chronic kidney disease-another drawback of immunosuppression?
    Malyszko J; Glowinska I; Mysliwiec M
    Transplant Proc; 2012 Dec; 44(10):3013-6. PubMed ID: 23195016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous erythropoietin levels and anemia in long-term renal transplant recipients.
    Zadrazil J; Horák P; Horcicka V; Zahálková J; Strébl P; Hrubý M
    Kidney Blood Press Res; 2007; 30(2):108-16. PubMed ID: 17374961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor deficiency in the anemia of renal transplant patients with grade III-IV chronic kidney disease: baseline results of the ARES Study.
    Gentil MA; Pérez-Valdivia MA; López-Mendoza M; Ortega F; Arias M; Gómez-Alamillo C; Campistol JM;
    Transplant Proc; 2008 Nov; 40(9):2922-4. PubMed ID: 19010148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of anemia in renal transplantation: impact of a stricter application of hemoglobin targets.
    Gentil MA; Pérez-Valdivia MA; González-Roncero FM; López-Mendoza M; Cabello V; Bernal G; Suñer M; Pereira P
    Transplant Proc; 2008 Nov; 40(9):2916-8. PubMed ID: 19010146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.
    Lezaic V; Biljanovic-Paunovic L; Pavlovic-Kentera V; Djukanovic L
    Eur J Med Res; 2001 Jan; 6(1):27-32. PubMed ID: 11313188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
    J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidence and management of anemia in renal transplantation: an observational-French study].
    Choukroun G; Deray G; Glotz D; Lebranchu Y; Dussol B; Bourbigot B; Lefrançois N; Cassuto-Viguier E; Toupance O; Hacen C; Lang P; Mazouz H; Martinez F
    Nephrol Ther; 2008 Dec; 4(7):575-83. PubMed ID: 18672417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anemia following renal transplantation: erythropoietin response and iron deficiency.
    Miles AM; Markell MS; Daskalakis P; Sumrani NB; Hong J; Sommer BG; Friedman EA
    Clin Transplant; 1997 Aug; 11(4):313-5. PubMed ID: 9267720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of anemia after late introduction of everolimus in the immunosuppressive treatment of renal transplant patients.
    Sánchez Fructuoso A; Calvo N; Moreno MA; Giorgi M; Barrientos A
    Transplant Proc; 2007 Sep; 39(7):2242-4. PubMed ID: 17889151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Soluble transferrin receptor and erythropoietin in chronic disease anemia with or without iron deficiency].
    Díaz de Domingo NB; Lardo MM; Gasparini S; Grinspon D; Cantenys N; Carbia CD; Merelli A; Sánchez Avalos JC
    Medicina (B Aires); 2001; 61(5 Pt 1):552-6. PubMed ID: 11725764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
    Wang W; Zhang MH; Yu Y; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy.
    Luna E; Cerezo I; Macias R; Villa J; Martinez C; Cubero J; Martinez R; Ferreira F; García C
    Transplant Proc; 2011; 43(6):2187-90. PubMed ID: 21839229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease.
    Wagner M; Alam A; Zimmermann J; Rauh K; Koljaja-Batzner A; Raff U; Wanner C; Schramm L
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1573-9. PubMed ID: 21734083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemia in pediatric renal transplant recipients.
    Kausman JY; Powell HR; Jones CL
    Pediatr Nephrol; 2004 May; 19(5):526-30. PubMed ID: 15007719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of erythropoietin in anemia after heart transplantation.
    Gleissner CA; Klingenberg R; Staritz P; Koch A; Ehlermann P; Wiggenhauser A; Dengler TJ
    Int J Cardiol; 2006 Oct; 112(3):341-7. PubMed ID: 16309765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An underappreciated problem in renal transplant recipients: anemia.
    Unal A; Sipahioglu MH; Akcakaya M; Tokgoz B; Sav T; Oymak O; Utas C
    Transplant Proc; 2008 Jun; 40(5):1399-403. PubMed ID: 18589116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia in kidney transplanted patients.
    Molnar MZ; Novak M; Ambrus C; Kovacs A; Pap J; Remport A; Szeifert L; Mucsi I
    Clin Transplant; 2005 Dec; 19(6):825-33. PubMed ID: 16313332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.